Given the critical role of APOC3 in triglyceride metabolism and its emerging connection to cardiovascular diseases [1,2], the discovery of these isoforms presents new opportunities for understanding APOC3 regulation and exploring potential therapeutic interventions. This evidence concerns the gene APOC3 and cardiovascular disorder.